Tan, Jia Ping
Liu, Xiaodong http://orcid.org/0000-0002-9315-3406
Polo, Jose M. http://orcid.org/0000-0002-2531-778X
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP2004627, APP1104560, Sinergy 2019251)
Article History
Received: 7 May 2023
Accepted: 12 February 2024
First Online: 17 April 2024
Competing interests
: J.P.T, X.L. and J.M.P. are co-inventors on two Patent Cooperation Treaty (PCT) patent applications (application numbers PCT/AU2021/051401 and PCT/AU2021/051402) filed by Monash University related to work on derivation of human iBlastoids and derivatives. J.M.P. is a co-inventor on a patent (WO/2017/106932) and is a co-founder and shareholder of Mogrify Ltd., a cell therapy company. X.L is a co-founder of iCamuno Biotherapeutics Ltd. The other authors declare no competing interests.